Recombinant Anti-CD89 x Anti-Malaria Antigen Bispecific Antibody (Tandem Diabody) (T-BSDB-134)

Recombinant Anti-CD89 x Anti-malaria antigen Bispecific Antibody (Tandem Diabody) is designed to be expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can retarget NK cells to genus plasmodium. It is designed for the research of Malaria therapy.

Datasheet INQUIRY

Specifications

Targets

CD89 & Malaria Antigen

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Malaria

Targets

Target 1

CD89

Gene ID

2204

UniProt ID

P24071

Alternative Names

FcαRI; FCAR; Fc fragment of IgA, receptor for; CD89; FcalphaRI; immunoglobulin alpha Fc receptor; Fc alpha receptor

Target 2

Malaria Antigen

Alternative Names

malaria antigen; parasitic protozoans

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "CD89 & Malaria Antigen"

See other bsAb targets related to "CD89"

See other bsAb targets related to "Malaria Antigen"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD89 x Anti-Malaria Antigen Bispecific Antibody (Tandem Diabody) (T-BSDB-134). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD89 x Anti-Malaria Antigen Bispecific Antibody (Tandem Diabody) (CAT#: T-BSDB-134)

Specifications

Targets

Customer Reviews and Q&As